Pfizer: Arthritis, Rheumatoid trials

The registry lists 152 Arthritis, Rheumatoid studies with Pfizer as lead sponsor. 2 are open to participants now and 105 have results posted.

Phase 1 24Phase 2 29Phase 3 18Phase 4 17No phase 65(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisCompletedNCT00383188Phase 2Results posted
• Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional TherapyCompletedNCT00303186Results posted
• Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisTerminatedNCT00273858Results posted
• Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid ArthritisCompletedNCT00195494Phase 4Results posted
• A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsACompletedNCT00195403Results posted
• Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In LuxemburgCompletedNCT00195338Results posted
• Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 WeeksCompletedNCT00147498Phase 2Results posted
• A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid ArthritisTerminatedNCT05891600
• Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily PracticeCompletedNCT01692899
• Impact Of RA Therapy Compliance On Patient-Reported OutcomesCompletedNCT01438892
• Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy VolunteersCompletedNCT01405118Phase 1
• PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed ConditionsCompletedNCT01362673Phase 1
• A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550CompletedNCT01277991Phase 1
• A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)CompletedNCT01184092Phase 1
• A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy SubjectsCompletedNCT01184001Phase 1
• Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy VolunteersCompletedNCT01166555Phase 1
• A Study To Estimate The Amount Of CP-690,550 (Study Drug) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of CP-690,550 In Tablet FormCompletedNCT01143805Phase 1
• Multiple Dose Escalation Trial Of PF-04308515 In Healthy VolunteersCompletedNCT01101932Phase 1
• CP-690,550 Pharmacokinetics In Healthy Chinese SubjectsCompletedNCT01101919Phase 1
• A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product TestersCompletedNCT01023100Phase 1
• Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid ArthritisCompletedNCT01008852Phase 2
• Health Outcomes in Rheumatoid Arthritis in GreeceCompletedNCT01001182
• Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA PatientsCompletedNCT00895050
• Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in TaiwanCompletedNCT00888576
• Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in SpainCompletedNCT00881881
• A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.CompletedNCT00838058Phase 1
• Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid ArthritisCompletedNCT00815906Phase 1
• A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4
• Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal VolunteersCompletedNCT00782600Phase 1
• Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in AustraliaCompletedNCT00751387
• A Study of ARRY-371797 in Patients With Rheumatoid ArthritisCompletedNCT00729209Phase 1
• Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis PatientsCompletedNCT00650455Phase 4
• Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid ArthritisCompletedNCT00641225Phase 1
• A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking MethotrexateCompletedNCT00620685Phase 2
• Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT00550355Phase 1
• Study Evaluating the Efficacy and Safety of EtanerceptCompletedNCT00546533Phase 4
• Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in JapanCompletedNCT00503503
• Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and ChildrenCompletedNCT00484809
• A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid ArthritisCompletedNCT00484237Phase 3
• Study Evaluating Health Related Utility in Rheumatoid ArthritisCompletedNCT00471874
• Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid ArthritisCompletedNCT00446784Phase 1
• Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid ArthritisCompletedNCT00443950Phase 3
• Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid ArthritisCompletedNCT00440492Phase 1
• Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid ArthritisCompletedNCT00267852
• Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsCompletedNCT00252668Phase 4
• Study Evaluating Enbrel in Patients With Rheumatoid ArthritisCompletedNCT00245934
• Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate TherapyCompletedNCT00244556Phase 4
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainCompletedNCT00195377
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in SpainCompletedNCT00195364
• Study Evaluating ERB-041 With Methotrexate in Rheumatoid ArthritisCompletedNCT00141830Phase 2
• Study Evaluating TMI-005 in Active Rheumatoid ArthritisCompletedNCT00095342Phase 2
• Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2